Although it is likely that other actions of VHL contribute to its tumour suppressor action in the kidney, activation of HIF (and more specifically HIF-2α) has been shown to be necessary and sufficient for growth of VHL defective CCRCC cells in xenograft assays (Kondo et al, 2002, 2003). This evidence concerns the gene VHL and neoplasm.